Berg Edward B 4
Research Summary
AI-generated summary
Vaxart (VXRT) SVP Edward Berg Receives Stock Awards
What Happened Edward B. Berg, Senior Vice President and General Counsel of Vaxart, received two compensation awards on March 16, 2026: 115,000 restricted stock units (reported as acquired at $0.00) and a 225,000-share stock option grant (reported as a derivative award at $0.00). The Form 4 shows no cash paid for these awards; the RSUs and option grant are compensation rather than open-market purchases.
Key Details
- Transaction date: 2026-03-16; Form 4 filed: 2026-03-18 (timely filing).
- Reported price/value: $0.00 for both the 115,000 RSUs and the 225,000-share option grant (code A = award/grant).
- Shares owned after transaction: Not specified in the information provided in this summary/Form 4 excerpt.
- Footnotes:
- F1 (RSUs): 115,000 RSUs vest 25% on each anniversary of the vesting commencement date (Mar 16, 2026); fully vested on the fourth anniversary (Mar 16, 2030).
- F2 (Options): 225,000-option grant vests 25% on Mar 16, 2027, then in 36 equal monthly installments; fully vested on Mar 16, 2030.
- No 10b5-1, tax-withholding, cashless exercise, or gift language noted in these entries.
Context These transactions are standard equity compensation grants to an executive. The RSU award and option grant are not purchases or sales on the open market; they reflect compensation and include multi-year vesting schedules. For retail investors, such awards signal management compensation alignment with shareholder value over time but are not direct indications of immediate insider buying or selling.